Stem Cell Platforms:
– Mesenchymal Stem Cells (MSC) from multiple tissue sources
– Expansion, banking, quality analysis, viability, and potency testing frameworks
Dendritic Cell Immunotherapy:
– Monocyte-derived dendritic cell processing
– Antigen loading strategies for personalized immune activation
– Quality control and immunophenotyping standards
Natural Killer (NK) Cell Therapy:
– NK cell enrichment and cytokine-driven activation protocols
– Functional cytotoxicity assessment against tumor targets
– Scalable expansion platforms suitable for translational programs